Charcot-Marie-Tooth Disease — Research Summary
Printed from RareWays (rareways.com.au) on 5 April 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Ratiometric fluorescence aptasensor based on hollow mesoporous silica for gentamicin detection.
Li Yuefan et al. — Talanta (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41671824/
- 2.
Polydopamine-sealed mesoporous silica nanocarriers loaded with organic UV filters for effective full-spectrum UV protection.
Kang Zixin et al. — Colloids and surfaces. B, Biointerfaces (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41610650/
- 3.
Ultrasound targeted microbubble destruction-assisted mesoporous silicon delivery of dexamethasone inhibits ulcerative colitis by regulating the MTDH/ACSL4/NF-κB pathway.
Kang Kai et al. — Life sciences (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41791486/
- 4.
Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption.
Shams Narges et al. — Biomaterials advances (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41604908/
- 5.
Nerve Ultrasound in Pediatric Polyneuropathies: A Systematic Review.
Maccora Simona et al. — Neuropediatrics (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41145127/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Recruiting — Monash University
https://clinicaltrials.gov/study/NCT06339190
- 2.
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting — Sanford Health
https://clinicaltrials.gov/study/NCT01793168
- 3.
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Recruiting — University of Iowa
https://clinicaltrials.gov/study/NCT01193088
- 4.
RFC1 Natural History Study
Recruiting — Prof. Dr. Matthis Synofzik
https://clinicaltrials.gov/study/NCT05177809
- 5.
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Recruiting — Michael Shy
https://clinicaltrials.gov/study/NCT01193075
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth disease is a group of inherited conditions that damage the peripheral nerves, causing progressive muscle weakness and reduced sensation, particularly in the feet, legs, and hands. It is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 people worldwide. There is currently no cure, but research into gene therapies and other treatments is advancing rapidly.
Most Recent Research
Gentamicin (GEN) is an aminoglycoside antibiotic widely used in animal husbandry because of its low cost and high therapeutic efficacy; however, its residues in milk pose a potential risk to food safety. In this study, a truncated aptamer (G41) with high affinity toward GEN was obtained through molecular docking and molecular dynamics simulations. Gold nanoclusters (Au NCs) were synthesized using an l-proline reduction method and conjugated with G41 via Au-S bonds to form Au NCs-Apt. Meanwhile, amino-functionalized hollow mesoporous silica (HMSN-NH2) was employed as a carrier to load rhodamine 6G (R6G), with Au NCs-Apt acting as a gating molecule to encapsulate R6G through electrostatic interactions.In the presence of GEN, the specific binding between GEN and G41 induced the dissociation of Au NCs-Apt from the surface of HMSN-NH2, resulting in the release of R6G and a significant enhancement of the fluorescence signal at 556 nm (I556), while the fluorescence signal of Au NCs at 442 nm (I442) remained essentially unchanged. The proposed sensor exhibited an excellent linear response over the concentration range of 20-4000 ng/mL (R2 = 0.9977) with a low detection limit of 2.36 ng/mL. Moreover, The aptasensor showed good repeatability, with relative standard deviations (RSD) below 5% based on three independent measurements (n = 3). In addition, the method was applied to the determination of GEN in spiked milk samples, affording recoveries in the range of 98.35-101.49%, demonstrating its applicability to complex sample matrices. By integrating HMSN with a ratiometric fluorescence aptasensing strategy, this study provides a highly stable and anti-interference analytical platform for the monitoring of antibiotic residues in food.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.